Indisulam

N/A

Report date: 2023/12/14 17:55:50
NME

Base Information

Drug NameIndisulam
Drug Alias Name英迪舒兰indisulamum吲地磺胺E-7070ER-35744
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCarbonic anhydrases inhibitors
TargetsCarbonic anhydrases
Therapy Area/IndicationsMetastatic breast cancerNeoplasm MetastasisKidney Neoplasms +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[10
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerNeoplasm MetastasisKidney Neoplasms +[9

Other Information

ATC CodeN/A
Related LinksKEGG